27 September 2024

Circulars No.7093, No.7106, No.7442, No.8044, and No.7228 for the year 2024 regarding medical devices recall and Field Safety Corrective Actions

Reference: CIR-2024-00000177

 

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated

 

Circular No.7093 for the year 2024 Product Information Update of Medical Products Containing Active Ingredient Naproxen

Circular No.7106 for the year 2024 regarding Recall of One lot of Brukinsa 80mg

Circular No. 7442 for the year 2024 regarding notifications of Field Safety Corrective Action

Circular No.8044 for the year 2024 regarding notifications of Field Safety Corrective Action

Circular No.7228 for the year 2024 regarding notifications of Field Safety Corrective Action

 

 

 

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

تقارير سلامة الوسائل الطبية0019-09-2024.pdf:

View Document

تقارير سلامة الوسائل الطبية +-03-09-2024.pdf:

View Document

تقارير سلامة الوسائل الطبية -+ 05-09-2024.pdf:

View Document

تحديث معلومات المنتجات الطبية التي تحتوي على المادة03.09.2024-.pdf:

View Document

Brukinsa 80 mg +-سحب تشغيلة واحدة من المنتج الطبي.pdf:

View Document